GINKGO BIOWORKS HOLDINGS, INCGINKGO BIOWORKS HOLDINGS, INCGINKGO BIOWORKS HOLDINGS, INC

GINKGO BIOWORKS HOLDINGS, INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−1.38MXN
Revenue estimate
‪761.90 M‬MXN
Market capitalization
‪36.27 B‬MXN
−7.80MXN
‪−15.17 B‬MXN
‪4.27 B‬MXN
‪1.35 B‬
Beta (1Y)
3.87

About Ginkgo Bioworks Holdings, Inc.

CEO
Jason Kelly
Headquarters
Boston
Employees (FY)
‪1.22 K‬
Founded
2008
FIGI
BBG01B347V79
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DNA is 14.94 MXN — it has decreased by 3.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange GINKGO BIOWORKS HOLDINGS, INC stocks are traded under the ticker DNA.
GINKGO BIOWORKS HOLDINGS, INC is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
DNA stock is 7.39% volatile and has beta coefficient of 3.87. Check out the list of the most volatile stocks — is GINKGO BIOWORKS HOLDINGS, INC there?
DNA earnings for the last quarter are −2.79 MXN per share, whereas the estimation was −1.59 MXN resulting in a −75.00% surprise. The estimated earnings for the next quarter are −1.64 MXN per share. See more details about GINKGO BIOWORKS HOLDINGS, INC earnings.
GINKGO BIOWORKS HOLDINGS, INC revenue for the last quarter amounts to ‪966.18 M‬ MXN despite the estimated figure of ‪837.99 M‬ MXN. In the next quarter revenue is expected to reach ‪721.90 M‬ MXN.
Yes, you can track GINKGO BIOWORKS HOLDINGS, INC financials in yearly and quarterly reports right on TradingView.
DNA stock has fallen by 5.74% compared to the previous week, the month change is a 27.09% fall, over the last year GINKGO BIOWORKS HOLDINGS, INC has showed a 42.76% decrease.
DNA net income for the last quarter is ‪−3.60 B‬ MXN, while the quarter before that showed ‪−5.28 B‬ MXN of net income which accounts for 31.90% change. Track more GINKGO BIOWORKS HOLDINGS, INC financial stats to get the full picture.
Today GINKGO BIOWORKS HOLDINGS, INC has the market capitalization of ‪34.25 B‬, it has decreased by 7.37% over the last week.
No, DNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GINKGO BIOWORKS HOLDINGS, INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 30, 2024, the company has ‪1.22 K‬ employees. See our rating of the largest employees — is GINKGO BIOWORKS HOLDINGS, INC on this list?
We've gathered analysts' opinions on GINKGO BIOWORKS HOLDINGS, INC future price: according to them, DNA price has a max estimate of 50.92 MXN and a min estimate of 16.97 MXN. Read a more detailed GINKGO BIOWORKS HOLDINGS, INC forecast: see what analysts think of GINKGO BIOWORKS HOLDINGS, INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GINKGO BIOWORKS HOLDINGS, INC EBITDA is ‪−10.82 B‬ MXN, and current EBITDA margin is −238.88%. See more stats in GINKGO BIOWORKS HOLDINGS, INC financial statements.